Exxua is the Red Headed Stepchild of Antidepressants


anonymous

Guest
It took 30 years for Exxua to get approved going from BMS, Organon and GSK. FDA approved it in 2023 but NO company wanted to sell it except us. What do they know that we don’t know?
 








What does this sh*tty product have to do with anything we currently do? More BS for us to learn, a new specialty, with me market opportunity. Another GP/JD pipe dream.
 


This company is a hobby for the twins. They make a great salary and benefits, and need things to do to fill their day. They are probably not getting the bump they were expecting in the stock price. Interesting to see what the financials look like for this quarter with this boondoggle.
 


I think the twins like this kind of stuff. They know GP will go into his old football glory days. But GP gets to play out his fantasy cheerleader role in skirt and pompoms while TC is still Waterboy.
 







Write your reply...